Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate

By Hart M.K.   Caswell-Stephan K.   Bakken R.   Tammariello R.   Pratt W.   Davis N.   Johnston R.E.   Smith J.   Steele K.  

Vaccine, Vol. 18, Iss. 26, 2000-07 ,pp. : 3067-3075

Elsevier

Access to resources Recommend Favorite

Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors

By Pasetti M.F.   Levine M.M.   Sztein M.B.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 401-418

Elsevier

Access to resources Recommend Favorite

Potency testing of a live, genetically attenuated vaccine for salmonids

By Marsden M.J.   Vaughan L.M.   Fitzpatrick R.M.   Foster T.J.   Secombes C.J.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1087-1094

Elsevier

Access to resources Recommend Favorite

Immunity to airborne challenge with Venezuelan equine encephalitis virus develops rapidly after immunisation with the attenuated vaccine strain TC-83

By Phillpotts R.J.  

Vaccine, Vol. 17, Iss. 19, 1999-05 ,pp. : 2429-2435

Elsevier

Access to resources Recommend Favorite

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus

By Riemenschneider J.   Garrison A.   Geisbert J.   Jahrling P.   Hevey M.   Negley D.   Schmaljohn A.   Lee J.   Hart M.K.   Vanderzanden L.   Custer D.   Bray M.   Ruff A.   Ivins B.   Bassett A.   Rossi C.   Schmaljohn C.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 4071-4080

Elsevier

Access to resources Recommend Favorite